KAI1 is a potential metastatic suppressor gene for prostate cancer. We found by Northern blot analysis that six of ten (60%) gastric and colon cancer cell lines exhibited undetectable or very low expression level of KAI1 mRNA. The eects of KAI1 on the adhesion, motility and invasiveness of colon cancer cells was therefore investigated by using two kinds of stable transfectants, i.e., antisense transfectants of BM314 cells whose KAI1 mRNA expression was suppressed by transfer of antisense KAI1 cDNA and sense transfectants of DLD-1 cells with the enhanced KAI1 mRNA by sense cDNA transfer. The following results were obtained: (1) KAI1 gene expression had no signi®cant eect on in vitro cell growth rate of colon cancer BM314 and DLD-1 cells; (2) Cell aggregation assay showed that KAI1 enhanced the Ca ++ -independent aggregatability of those colon cancer cells; (3) It was revealed by cell motility and invasion assays that KAI1 suppressed both the motility and in vitro invasiveness of those cells and (4) Furthermore, both the binding to ®bronectin and the migration on ®bronectin-coated plates of those cells were inhibited by KAI1 expression. These suggest that reduced KAI1 gene expression may contribute to the invasiveness and metastatic ability of colon cancer cells.
Introduction
Colon cancer has recently been increasing as one of the most common cause of cancer death of both men and women in Japan (Ministry of Health and Welfare, 1996) . Although endoscopic treatments have been greatly improved in early stage of colon cancer, there is no established treatment for the late stage which is characteristic of invasion into neighboring organs, or distant metastasis. Tumor metastasis, a leading cause of death for cancer patients, involves a multistep process which is determined by both properties of metastatic cancer cells and their interactions with the host (Poste and Barsky, 1980; Fidler and Hart, 1982; Liotta and Fidler, 1983; Liotta and Stetler-Stevenson, 1991; Aznavoorian et al., 1993) . The genetic events that suppress or induce tumor metastatic process remains least understood aspects of cancer. Evidence on genetic alterations in oncogenes and tumor-suppressor genes had encouraged the search for genes that may induce or suppress tumor invasion and metastasis. A number of negative eector genes have been identi®ed as being implicated in invasion and metastasis. Among them, the nm23 gene, with potential tumor-suppressor function, had been reported to be negatively correlated with metastatic potential in certain spontaneous and experimental tumors (Barnes et al., 1990; . Recent con¯icting results, however, have revealed no signi®cant relationship between Nm23 expression and metastatic ability of colon cancer cells (Haut et al., 1988; Cohn et al., 1991; Myero and Markowitz, 1993; Wang et al., 1993; Whitelaw and Northover, 1993) . DCC also seemed to be a candidate tumor suppressor gene, deletions and somatic mutation of which have been observed in a number of colorectal cancers (Fearon et al., 1990; Ookawa et al., 1993) . Our previous report showed some relationship between colon cancer DCC mRNA expression and the presence of liver metastasis (Itoh et al., 1993) . Its structural homologies with the neural cell adhesion molecule (N-CAM) and other related cell surface glycoproteins suggest that DCC might be involved in cell adhesion, but its function is yet to be completely elucidated. Recently, E-cadherin, a putative invasion suppressor gene, has been reported to modulate the invasiveness of various carcinoma cells (Behrens et al., 1989; Frixen et al., 1991; Ueda et al., 1991) . However, a clear-cut relationship between invasiveness and Ecadherin expression was not found in all tumor-cell systems (Behrens et al., 1993) .
A recent study by Dong et al. (1995) has identi®ed a potential marker for metastatic prostate cancer, KAI1, a metastatic suppressor gene localized to chromosome 11p11.2. KAI1 expression is reduced in human cell lines derived from metastatic prostate cancers, compared with its expression in normal prostate tissue. The introduction of KAI1 into a rat prostate cancer cell line, AT6.1 signi®cantly suppressed pulmonary metastases in nude mice. KAI1 speci®es 267 amino acids, and has a characteristic polypeptide chain containing four hydrophobic, presumably membrane-spanning segments and a single major presumably extracellular domain with three potential N-glycosylation sites. Thus, KAI1 belongs to a structurally related family of membrane glycoproteins named`transmembrane 4' (TM4) or`tetra spans transmembrane' (TST) family (Boucheix et al., 1991; Horejsi and Vlcek, 1991; Gil et al., 1992; Wright and Tomlinson, 1994) , most of which have been identi®ed as leukocyte surface proteins (Horejsi and Vlcek, 1991) . KAI1 cDNA sequence revealed that KAI1 is identical to three cDNA clones from human leukocytes, designated by C33 Imai et al., 1992) , R2 (Gaugitsch et al., 1991) , and IA4 (Gil et al., 1992) , which has been assigned the CD-names : CD82. KAI1 shows its expression not only in the prostate but in a wide variety of tissues including the intestine and colon. It is thus intriguing to hypothesize that KAI1 may play a universal role in suppressing metastases of other tissuederived cancers.
Our research question concerning KAI1 is whether its reduced expression is associated with or causes highly metastatic behavior in colon cancer cells. In the present study, we describe the transfection of human KAI1 cDNA into two kinds of colon cancer cell lines both in the sense direction and in the antisense direction, and analyse their resultant phenotypic changes with bidirectional regulations of KAI1 gene expression. We demonstrate the potential involvement of KAI1 in the invasion and metastasis of colon cancer cells.
Results

Expression of KAI1 mRNA in gastric and colon cancer cell lines
To evaluate the expression of KAI1 message in several gastric and colon cancer cell lines, we performed Northern blot analyses using the cDNA as probe, which exhibited various dierences in the level of expression among those cell lines examined. In gastric cancer cell lines ( Figure 1a , lanes 1 to 5), the 2.4 kb KAI1 transcript was detected most abundantly in MKN74 (lane 4): moderately abundant in JRST (lane 2), while MKN45 (lane 3) showed relatively slight expression of KAI1 mRNA, and AZ521 (lane 1) and NUGC3 (lane 5) revealed loss of KAI1 mRNA expression. In colon cancer cell lines ( Figure 1a , lanes 6 to 10), KAI1 message was observed in BM314 (lane 6) and Colo201 (lane 8), but not in CHCY-1 (lane 7), Colo320DM (lane 9) and DLD-1 (lane 10). BM314 and DLD-1 cells were used for the following antisense and sense KAI1 cDNA transfection, respectively.
Preparation of antisense and sense KAI1 transfectants
To analyse the role of KAI1 in motility and metastatic process of colon cancer cells, stable transfectants in both the sense and the antisense directions were established. BM314 cells with endogenous KAI1 mRNA expression and DLD-1 cells with its least expression were transfected with antisense and sense KAI1 cDNAs, respectively. Cells transfected with only an expression vector pRc/CMV served as a control. Expression of KAI1 gene in resultant transfectant clones was analysed by reverse transcriptasepolymerase chain reaction (RT ± PCR) (Figure 2) , showing the 801 bp band predicted for primer pair 1 and 2 with dierent expression levels. In antisense transfectants (Figure 2a ), clone 3 with highly suppressed endogenous KAI1 mRNA expression named as BM/ as77 and clone 5 with moderate suppression named as BM/as7 were chosen as negatively regulated clones for KAI1 gene expression and were analysed for further functional experiments. In sense KAI1 transfectants (Figure 2b ), clone 8 with high expression level of KAI1 mRNA named as DLD/s++ and clone 9 with moderate expression named as DLD/s+ were chosen as positively regulated clones for KAI1 expression. Control clones for sense and antisense KAI1 transfectants were named as DLD/con and BM/con, respectively.
Detection of KAI1 protein in transfectants by¯ow cytometry
To con®rm the expression of KAI1 gene at the protein level,¯ow cytometry using permeabilized transfectants (Figure 3 ). Percentages of positive cells of DLD/con, DLD/s+ and DLD/s++ were 1.1%, 85.5% and 95.1%, respectively. BM/con also clearly reacted with the anti-KAI1 antibody whereas BM/as7 and BM/as77 were weakly and faintly positive, respectively (data not shown).
Eect of KAI1 on in vitro growth of colon cancer cells
The in vitro cell growth rates of both antisense and sense KAI1 transfectants and control clones measured by MTT assay are graphed in Figure 4 . The growth rates of antisense KAI1 transfectants (BM/as77, BM/as7) and control cells (BM/con) were virtually superimposable, as were the curves for sense KAI1 transfectants (DLD/s++, DLD/s+) and control cells (DLD/con). These revealed that neither expression nor suppression of KAI1 message aected the in vitro growth rate of those two colon cancer cell lines. Cell viability was greater than 98% in all cultures.
Eect of KAI1 on aggregatability of colon cancer cells
Since some members of the TM4 family have been shown to be related with intercellular adhesion, cell aggregation assay was performed to reveal if KAI1 is also involved in it. Single cell suspensions of sense and antisense transfectants were prepared and allowed to aggregate in saline with either 0 or 5 mM Ca ++ at 378C for 1 or 2 h. As shown in Figure 5a and Figure 5b , antisense KAI1 transfectants BM/as77 cells showed signi®cantly decreased cell aggregation as compared with BM/con cells at 2 h after culture irrelevant of the addition of 5 mM Ca ++ (**P50.01). On the contrary, a signi®cant increase of cell aggregation was observed in sense KAI1 transfectants DLD/s++ and DLD/s+ cells at 1 h and 2 h after culture under the Ca ++ free conditions (Figure 5c ) (**P50.01). This trend was not aected by the addition of 5 mM Ca ++ (Figure 5d ), although a signi®cant dierence was obtained only in DLD/s++ at 2 h after culture. These results indicate that KAI1 is involved in the cell to cell adhesion of colon cancer BM314 and DLD-1 cells.
Eect of KAI1 on motility and invasive ability of colon cancer cells
To explore if KAI1 has some roles as an invasion suppressor in colon cancer cells, phagokinetic motility of sense and antisense transfectants was investigated by using a gold-particle coating method. Areas of the particle-clear zone for each clone were measured after a 24 h incubation, and the average area was calculated. As shown in Figure 6a , antisense KAI1 transfectants BM/as77 and BM/as7 showed increased cell motility dependent on the degree of KAI1 mRNA suppression (**P50.01). BM/as77 and BM/ as7 cells exhibited a ®vefold and a 2.7-fold higher basal phagokinetic activity than BM/con cells, respectively. Reversely, phagokinetic motility was suppressed in sense KAI1 transfectants DLD/s++ and DLD/s+ in an expression level dependent manner, which were 0.36 and 0.67 times compared with that of DLD/con cells, respectively ( Figure 6b ) (*P50.05, **P50.01). The results obtained revealed that KAI1 negatively regulates the phagokinetic motility of those colon cancer cells. We then performed in vitro cell invasion assay. The number of migrated cells through the ®lter coated by reconstituted basement membrane was counted. Results of three independent experiments for comparative invasiveness among sense and antisense transfectants are presented in Figure 7 . Antisense KAI1 transfectant BM/as77 cells showed significantly enhanced invasiveness as compared with control BM/con cells (*P50.05), whereas a significant suppression of invasion was observed in sense KAI1 transfectant DLD/s++ cells compared with DLD/con cells (**P50.01). These indicate that KAI1 suppresses the in vitro invasive ability of those colon cancer cells.
Eect of KAI1 on binding of colon cancer cells to extracellular matrices
Tumor cells interact with extracellular matrix (ECM) components and basement membrane, which is an essential initial event during the process of invasion and metastasis. To analyse the mechanism for the decreased invasion of BM314 and DLD-1 cells, we examined the eect of KAI1 gene expression on the binding of sense and antisense transfectants to ECMs, ®bronectin, type IV collagen, type I collagen and laminin by using cell attachment assay. As a result, only ®bronectin showed a signi®cant eect on the binding of KAI1 transfectants. ++ . The degree of aggregate was examined under a microscope, and results were expressed as a percent of total cell numbers forming aggregates at speci®c time points as indicated.
The percent values represent a mean of triplicates with standard error. Asterisks indicate that the dierences were statistically signi®cant (*P50.05, **P50.01) Figure 6 Eect of antisense or sense KAI1 gene transfer on motility of colon cancer cells as determined by phagokinesis on gold colloid method. BM314 transfectants with antisense KAI1 cDNA (a) and DLD-1 transfectants with sense KAI1 cDNA (b) were plated on colloidal-gold-coated coverslips in culture medium. After 24 h, cells were photographed and areas cleared by migration of each clone were measured for cell motility. Shown in the ®gure are means+s.e.m.s (n=30). Asterisks indicate that the dierences were statistically signi®cant (*P50.05, **P50.01) Figure 7 Eect of antisense or sense KAI1 gene transfer on invasive ability of colon cancer cells. BM314 transfectants with antisense KaI1 cDNA (a) and DLD-1 transfectants with sense KAI1 cDNA (b) were incubated using transwell chambers equipped with reconstituted basement membrane-coated ®lters for 24 h. Cells which had migrated through the membrane and stuck to the lower surface of the ®lter were counted under a microscope in ®ve pre-determined ®elds at a magni®cation of 6200. The bars represent the standard error of the mean of three separate experiments. The dierences observed between BM/ as77 or DLD/s++ and each control were statistically signi®cant (*P50.05, **P50.01) BM/con cells (**P50.01), whereas a signi®cant decrease of binding to ®bronectin of DLD/s++ cells was observed when compared with DLD/con cells (**P50.01). To analyse the eect of KAI1 gene transfer on the expression of ®bronectin receptors in BM314 and DLD-1 cells,¯owcytometry with monoclonal antibodies (mAbs) was performed. There was no signi®cant dierence on CD49c and CD49e expression levels between transfectants and their controls, i.e., sense and antisense KAI1 transfectants equally expressed a3b1 integrin, whereas none of them expressed a5b1 integrin (data not shown). These data show that expression of KAI1 gene prevents those colon cancer cells from binding to ®bronectin.
Eect of KAI1 on locomotion of colon cancer cells on ®bronectin-coated plates
Modi®ed wound assay using ®bronectin-precoated culture plates was then performed to further study the signi®cance of decreased binding of KAI1-expressed colon cancer cells to ®bronectin. The cell migration was quantitated by calculating the percentage of width of wounded area ®lled by the migrated cells to that of wounded area at the beginning of the assay. As shown in Figure 9a , antisense KAI1 transfectant BM/as77 cells demonstrated a significant increase in cell migration on the ®bronectin-coated surface as compared with control cells (**P50.01). No signi®cant dierence was seen among antisense KAI1 transfectants on non-treated plates. Figure 9b presents the results for sense KAI1 transfectants where the converse trend was apparent, in comparison with those for antisense transfectants.
Sense KAI1 transfectant DLD/s++ cells showed a signi®cantly decreased cell migration on ®bronectin-coated surfaces compared to control DLD/con cells, but not on non-treated surfaces (**P50.01). These ®ndings indicate that KAI1 suppresses the ®bronectin-mediated locomotion of colon cancer BM314 and DLD-1 cells at least partly through decreasing their motility and binding ability to ®bronectin.
Immunohistochemical detection of KAI1 protein in colon cancer tissues
We attempted the preliminary immunohistochemical studies of 14 primary and four liver-metastatic colon cancer tissue specimens ®xed with AMeX method (Sato et al., 1986 ) using anti-KAI1 antibody against C-terminal peptide to study the clinical signi®cance of KAI1 expression in colon cancer. Primary tumors were histologically classi®ed into three groups, i.e. four well dierentiated, seven moderately dierentiated and three poorly dierentiated adenocarcinomas. The entire area of one section per each tissue specimen was evaluated. The staining intensity of well or moderately dierentiated adenocarcinoma was almost the same as that of normal epithelial cells. Interestingly, a total loss of KAI1 protein expression was observed in one out of 14 primary colon cancer tissue specimens whose histological type was poorly differentiated adenocarcinoma. Furthermore, two of four metastatic cancer tissue specimens did not express KAI1 protein in spite of the fact that the corresponding primary lesions were positive for the antibody. Their representative ®ndings are shown in Figure 10 . Asterisks indicate that the dierences were statistically significant (**P50.01) Figure 9 Eect of antisense or sense KAI1 gene transfer on the ®bronectin-mediated migration of colon cancer cells. Con¯uent cultures of sense or antisense KAI1 transfectants on ®bronectin-coated dishes were wounded with a disposable pipette tip as described in Materials and methods. Then, photographs were taken, compared to the photos after 24 h-incubation, and migration was quantitated by calculating the ®lling rate of the wounded area as described. Each sample was tested in triplicate and data represent the mean plus or minus the standard error. Both antisense KAI1 transfectants (a) and sense KAI1 transfectants (b) were examined in this assay. Asterisks indicate that the dierences were statistically signi®cant (**P50.01). FN indicates ®bronectin
The cytoplasm except for mucus was positively immuno-stained in normal colon epithelial cells (Figure 10a ). Some mononuclear cells in the lamina propria of the colon (Figure 10a ) and in the noncancerous region of the liver (Figure 10c) were also positive.
Discussion
The ®rst report about the cloning of KAI1 gene indicated that KAI1 gene has suppressive eects on the metastasis of the rat prostate cancer. They also showed that the introduction of KAI1 gene by microcell-mediated chromosome transfer method resulted in no eect on their metastatic ability of highly metastatic rat mammary cancer cells despite the certain amounts of KAI1 expression (Rinker-Schaeer et al., 1994; Dong et al., 1995) . Furthermore, a recent immunohistochemical study has shown that the presence of KAI1 protein in prostate cancer has a negatively correlated with advanced clinical stages (Ueda et al., 1991) . These ®ndings seem to suggest that KAI1's capability of metastasis suppression may have a tumor-speci®c action and be limited to prostate cancers (Marx, 1995) . However, there have recently been several studies upon the association of KAI1 expression with clinicopathological characteristics, which support the possibility that KAI1 could have a metastasis suppressor eect in other kinds of tumors as well as in prostatic cancer. It was documented that conserved KAI1 gene expression is associated with good prognosis in patients with non-small cell lung cancer, suggesting that the levels of expression of KAI1 gene may be a potent prognostic factor . Evaluation of KAI1 mRNA expression in relation with clinical parameters of pancreatic cancer patients revealed that the levels of KAI1 mRNA expression is signi®cantly down-regulated in pancreatic cancer patients with advanced tumor stages with lymph node metastasis compared with those without it (Guo et al., 1996) . These observations and the broad tissue distribution of KAI1 message (Dong et al., 1995) suggest a more universal role of KAI1 as a metastasis suppressor. Normal small intestine and colon tissues were found to express KAI1 message (Dong et al., 1995) , but there have been no reports on the expression and functional analyses of KAI1 in gastrointestinal cancers. In the present study, we therefore examined the expression of KAI1 mRNA in various gastric and colon cancer cell lines. Northern blot analysis revealed undetectable or very low expression level of KAI1 message in six of ten (60%) gastric and colon cancer cell lines. To study the eect of KAI1 on the invasive and metastatic properties of colon cancer cells, we then prepared stable KAI1 transfectants using human colon cancer cell lines. A key aspect of our study has been to use both the antisense and sense KAI1 transfectants to ensure the reproducibility of obtained data, i.e., antisense transfectants of BM314 cells whose KAI1 mRNA expression was suppressed by transfer of antisense KAI1 cDNA and sense transfectants of DLD-1 cells with the enhanced KAI1 mRNA by sense cDNA transfer.
In cell aggregation assay, antisense and sense KAI1 transfectants exhibited decreased and increased aggregatability, respectively, as compared with each control. This suggests an important role of KAI1 in intercellular adhesion. There have been several lines of evidences showing the involvement of TM4 family members in cell adhesion. C33 antigen which is identical to KAI1 had been identi®ed as the target antigen of a mAb inhibitory to HTLV-1-induced syncytium formation . This antigen is thought not to a b c Figure 10 Immunohistochemical detection of KAI1 protein in a case of colon cancer with liver metastasis. Normal colonic epithelium adjacent to cancer region (a) (6190) and the primary cancer tissue (b) (6190) were positively immunostained whereas the metastatic lesion in the liver (c) (6190) was negative
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A Takaoka et al be the HTLV-1 receptor itself, but to be involved in cell adhesion in the process of HTLV-1-induced syncytium formation in human T cells. Also, other members of the TM4 family have been shown to be involved in the regulation of cellular adhesion; stimulation of CD9 by mAb induces homotypic adhesion of pre-B cell lines (Straus et al., 1989) and platelet aggregation (Schaepfer et al., 1994) , antibody against CD81 triggers homotypic adhesion of various lymphoid cell lines (Takahashi et al., 1990) , and rat CD53/OX-44 is associated with CD2, the adhesion receptor in activated T cell and NK cell lines (Bell et al., 1992) . Considering these observations, our data suggest that reduced expression of KAI1 gene in colon cancer cells results in the suppressive eect on cell-tocell adhesion. These data also propose a hypothesis that detachment from primary lesion might be one of the aspects where KAI1 would aect as a suppressive regulator of the metastatic process. Further studies are required to determine whether KAI1 participates directly or indirectly in the homotypic aggregation of colon cancer cell lines. To see the eect of KAI1 expression on the invasive properties of colon cancer cells, we carried out phagokinetic track assay ( Figure 6 ) and in vitro invasion assay (Figure 7) . They revealed the negative correlation between the expression level of KAI1 mRNA of sense transfectants and their motility or invasiveness, which was con®rmed by the assays with antisense KAI1 transfectants. Of interest is the observation on the CD9/MRP-1 antigen and CD63/ ME491 that belong to other members of the TM4 family. CD9/MRP-1 has been reported to have little eect on the proliferation of some tumor cell lines including lung adenocarcinoma MAC10 . The introduction of CD9/MRP-1 into a mouse malignant melanoma cell line showed its diminished cell motility and pulmonary metastatic potential . Furthermore, the CD9/MRP-1 expression has been reported to be inversely correlated with the progression of lymph node metastasis in breast cancer . Likewise, the CD63/ME491, a stage-speci®c melanoma-associated antigen, has been described as being not detected in normal melanocyte, but abundantly expressed in human malignant melanoma and precancerous regions of melanoma, and further reduced in dermis-invading and metastatic melanomas. The reduced expression of CD63/ME491 antigen is thought to be associated with enhanced invasive and metastatic abilities of human malignant melanoma (Hotta et al., 1988; Kondoh et al., 1993; Azorsa et al., 1991) . These suggest that antiinvasive and metastatic eect may be shared by some members of the TM4 family. In this context, it is obviously important to observe if KAI1 aects the in vivo invasive and metastatic abilities of tumor cells. However, we have not thus far obtained any data on the in vivo behavior of KAI1 cDNA-transfected BM314 and DLD-1 cells, because those cell lines did not show metastasis at all when transplanted in immunode®cient mice. We have examined the eect of KAI1 on the experimental metastasis of KAI1 cDNA-transfected mouse melanoma B16 cells. As a result, the number of metastatic nodules of lungs were signi®cantly decreased in KAI1 transfectants compared to mock transfectants and parental cells (unpublished data).
Furthermore, preliminary immunohistochemical staining was performed for surgically resected 14 human colon cancer tissue specimens. A total loss of KAI1 protein expression was observed in one primary colon cancer tissue specimen whose histological type was poorly dierentiated adenocarcinoma, and in two livermetastasis specimens in spite of the fact that the corresponding primary lesions were positive for the anti-KAI1 antibody. When some tumor cell clones acquire the lower expression level of KAI1, they might metastasize to the liver. Taken together, these data may suggest the possible involvement of KAI1 in the in vivo metastasis of tumor cells.
Attachment of cancer cells to ECM and subsequent cellular movement are essential steps for invasion. To analyse the mechanism for the decreased invasiveness of BM314 and DLD-1 cells by KAI1 expression, we examined the eects of KAI1 on the adhesive ability of colon cancer cells to several ECMs. With increasing the level of KAI1 expression, sense KAI1-transfected clones showed the reduced ability to bind to ®bronectin, whereas the inverse trend was observed in the antisense KAI1-transfected clones. For the interaction with other ECMs, type IV collagen, type I collagen and laminin, no signi®cant eect on the binding ability of KAI1 transfectants was observed. These data facilitated us to investigate whether KAI1 may in¯uence the regulation of the expression level of ®bronectin receptors. However, the¯ow cytometric analysis showed that there was no dierence of the expression level of a3b1 integrins known as ®bronectin receptors among those transfectants (Chintala et al., 1996; Wu et al., 1993; Ruoslahti, 1996) . To further examine the eect of KAI1 on the interaction of colon cancer cells with ®bronectin, the ®bronectin-mediated locomotion of KAI1 transfectants was observed by using wound assay (Figure 9) . A negative eect of KAI1 on the locomotion of those cells on ®bronectin-coated surfaces was consequently obtained, suggesting the importance of ®bronectin for the expression of anti-invasion eect of KAI1.
It should be noted here that KAI1 could aect the binding and locomotion of BM314 and DLD-1 cells on ®bronectin-coated surfaces without any in¯uences on the expression level of ®bronectin receptors. A presumption from these results is that KAI1 might have some involvement in regulating the function of ®bronectin receptors. Previous reports showed that ®bronectin receptors function not only in attachment or cellular adhesion, but in an intracellular signaling system where the binding of ®bronectin to a cellsurface ®bronectin receptor conveys controlling signals to cell locomotion (Liotta et al., 1986; Straus et al., 1989; Fearon, 1993; Schaepfer et al., 1994) . As reported for CD82/KAI1 expressed on hematopoietic cells, CD82 may play an essential role as a regulator molecule in some signal transduction pathways, and engagement of CD82/KAI1 delivers dierent signals on the cell type; for example, a costimulatory signal for full activation for the human T cell line, Jurkat (Lebel-Binay et al., 1995a) , or an enhancing signal in FcR-mediated activation of monocyte/macrophage cell lines (Lebel-Binay et al., 1995b) . Some members of the TM4 family including CD82/KAI1 have been demonstrated to form multimolecular membrane complexes by structurally or functionally associating with each member and with other molecules, many of which appear to be involved in signal transduction. CD9/MRP-1 have been demonstrated to be associated with VLA integrins in the pre-B cell and megakaryocytic cell lines, and this association aected aggregation and migration of the two cell lines (Rubinstein et al., 1994) . In accordance with a signaling function, CD9/MRP-1 is reported to associate with small GTP-binding proteins (Seehafer and Shaw, 1991) . This report is intriguing with a view point that both CD9/MRP-1 and CD82/KAI1 belong to the TM4 family, and are furthermore involved in cell migration, invasion, and metastasis. These ®ndings provide some speculations that KAI1 alone or with other member(s) might be involved to some extent in modulating the intracellular signaling for cell locomotion. Further studies are in progress in our laboratory to investigate some involvement of KAI1 with integrins.
Our current data using sense and antisense KAI1 transfectants clearly showed the suppressive eect of KAI1 on the intercellular adhesion, attachment to ECMs, cell motility and invasiveness of colon cancer BM314 and DLD-1 cells. However, if the functions of KAI1 are of real importance in those cells, the eect of KAI1 would also be observed in parental cells. Indeed, in cell aggregation assay, BM/con cells showed a tendency of higher aggregatability under the Ca ++ -free conditions than DLD/con cells as shown in (Figure 5 ). DLD-1 cells (DLD/con) which has by far least expression of KAI1 message (Figure 1 ) tended to demonstrate better migratory and invasive responses than BM314 cells (BM/con) which express certain amounts of KAI1 mRNA (Figure 1) as shown in Figures 6 and 7 . Also, a tendency of higher ®bronectin-mediated locomotion of DLD/con cells was observed as compared to that of BM/con cells (Figure 9 ). These data may strengthen the ®ndings obtained by using KAI1 transfectants.
Materials and methods
Tumor cell lines and culture conditions
Both gastric and colon cancer cell lines used for these studies were obtained from the Japanese Cancer Research Resources Bank. Gastric cancer cell lines, AZ521, JRST, MKN45, MKN74, NUGC3, were maintained in RPMI 1640 supplemented with 10% fetal bovine serum (FBS). Colon cancer cell lines, CHCY1, Colo201, Colo320DM, DLD-1 except BM314 were maintained in the same way. BM314 cells were maintained in Dulbecco's modi®ed minimum essential medium containing 10% FBS. Cell cultures were maintained and incubated in 5% CO 2 -95% air at 378C.
Northern blot analysis of tumor cell lines
Total RNA was extracted from the indicated cell lines using ISOGEN kit (Nippon Gene, Toyama, Japan) according to the manufacturer's protocol. Ten mg of each RNA sample per lane was fractionated through a 1.0% agarose gel containing 2.2 M formaldehyde, and transferred to a nitrocellulose membrane in 106SSC. Hybridization to 32 P-labeled full-length of KAI1 cDNA was carried out in 50% formamide, 56SSPE (16SSPE=0.18 M NaCl, 10 mM sodium phosphate, pH 7.7, 1 mM EDTA), 56Denhart's solution, 5 mM EDTA, 0.1% SDS, and 100 mg/ml denatured salmon sperm DNA at 428C for 18 h. The ®lters were washed twice in 26SSC, 0.1% SDS at room temperature for 10 min and twice in 0.16SSC, 0.1% SDS at 558C for 10 min. KAI1 cDNA probe was radiolabeled with a-32 P-dCTP by random priming. After hybridization, all blots were exposed to Kodak XAR ®lms with an intensifying screen at 7708C. As a control for the amount of mRNA loaded, rRNAs were stained with ethidium bromide.
RT ± PCR and Southern blot analysis of stable transfectants
According to the nucleotide sequence of the R2 cDNA identi®ed by Gaugitsch et al. (1991) , speci®c PCR primers were designed to recognize the full coding region of KAI1 cDNA: forward`HindIII-MGSACIK' primer, 5'-CC-AAG-CTT-ATG-GGC-TCA-GCC-TGT-ATC-AAA-G-3', primer 1; reverse`HindIII-TCA-YKPVKS' primer, 5'-CC-AA-GC-TTTCA-GTA-CTT-GGG-GAC-CTT-GCT-G-3', primer 2. One mg of total RNA was reverse-transcribed with random nanomers and avian myeloblastosis virus reverse transcriptase using RT ± PCR kit (Takara, Otsu, Japan) following the conditions of the manufacturer. The template cDNAs were ampli®ed with Taq polymerase in the presence of primers 1 and 2 on the basis of PCR protocol (Saiki et al., 1985) . The thermocycling parameters used in the PCR were as follows: denaturation, 30 s at 948C; annealing, 30 s at 608C; extension, 1.5 min at 728C. These reactions were repeated for 30 cycles. The PCR products were electrophoresed through a 2.0% agarose gel and blotted onto nylon membranes (Hybond-N, Amersham, Arlington Heights, IL) in alkaline solution (0.25 M NaOH, 0.4 M NaCl) by capillary transfer. The full-length KAI1 cDNA probe was labeled with a-32 P-dCTP using a random primer labeling kit (Takara, Otsu, Japan). The ®lters were hybridized with 32 P-labeled KAI1 cDNA probe in 50% formamide, 56Denhart's solution, 36SSC, 100 mg/ml salmon sperm DNA, 1% sodium dedecyl sulfate (SDS) at 428C overnight. The membranes were then washed three times in 26SSC, 0.1% SDS at room temperature for 10 min and twice in 0.16SSC, 0.1% SDS at 558C for 15 min, and exposed to Kodak XAR ®lms at 7708C with an intensifying screen. Similarly, b-actin was ampli®ed and hybridized with 32 P-labeled b-actin cDNA probe for an internal control. The eect of antisense RNA on endogenous KAI1 mRNA expression level was investigated by RT ± PCR analysis using primer 1 and primer 3, 5'-CCTCCTCCCCAATTTTTCATACAGTTGC-CC-3', which was designed to be corresponded to the part of 3'-untranslated region from nucleotide position 1284 to 1313 (Gaugitsch et al., 1991) to speci®cally amplify the endogenous KAI1 mRNA.
Flow cytometric analysis
The transfectants were removed from plastic surface by 5 min incubation at 378C with 5 mM EDTA-PBS. After washing with cold phosphate-buered saline (PBS), the cells were permeabilized with cold ethanol for 5 min, and washed again. They were then incubated with an appropriate dilution of anti-KAI1 polyclonal antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) or of rabbit serum as a negative control for 30 min at 48C. After being washed three times with cold PBS, they were incubated with¯uorescein isothiocyanate-labeled goat antibody to rabbit immunoglobulins (Dakopatts, Copenhagen, Denmark) for 30 min at 48C. Washing was repeated in the same manner, and cell surface immuno¯uorescence was analysed by¯ow cytometry (Cytron, Ortho, Coulter Electronics, FL). To detect integrins on transfectants, the Invasion suppression of colon cancer cells by KAII gene A Takaoka et al unpermeabilized cells were incubated with an appropriate dilution of a monoclonal antibody against either human a5b1 integrin (CD49e) (0.2 mg/ml, Pharmingen, San Diego, CA) or human a3b1 integrin (CD49c) (0.5 mg/ml, Immunotech, Marseille, France) for 30 min at 48C. After incubation with the primary antibody, the cells were washed and incubated with¯uorescein isothiocyanatelabeled goat antibody to mouse IgG as described above, and were subjected to¯ow cytometry.
Constructs
The eukaryotic expression vector (pRc/CMV) was obtained from Invitrogen (San Diego, CA). The vector was designed for high-level stable expression, containing the cytomegalovirus promoter and enhancer and neomycin-resistant gene for the selection of stable transformants. In order to clone the full-length cDNA encoding human KAI1 into the expression vector pRc/CMV, the entire coding region of KAI1 cDNA was ampli®ed from total RNA derived from normal colon mucosa by RT ± PCR using primers 1 and 2 as described above. The resulting 803 bp PCR product was digested with HindIII, and subcloned into the HindIII site of pRc/CMV vector. Both sense (KAI1/CMV-s) and antisense (KAI1/CMV-as) orientations were prepared. Con®rmation of the constructs was obtained by dideoxy sequencing.
Transfection procedures and selection of stable clones
Sense cDNA of KAI1 (KAI1/CMV-s) was transfected into DLD-1 cells, which constitutively expressed KAI1 mRNA, while antisense cDNA of KAI1 (KAI1/CMV-as) was introduced into BM314 cells, which showed least expression of endogenous KAI1 mRNA. Transfections were initiated following the Lipofection (GIBCO BRL, Grand Island, NY) technique. Brie¯y, media was changed to OPTI-MEM I, reduced serum medium (GIBCO BRL). Two mg of plasmid was mixed with 10 ml of LIPOFEC-TAMINE, reagent, incubated in a six-well tissue culture plate of 70% con¯uent cells for 5 h at 378C in a CO 2 incubator. Following incubation, FBS was added to the plates (®nal FBS concentration was 10%), and cell cultures were incubated for 48 h. Cells were detached by trypsin-ethylene diamine tetraacetic acid (EDTA) solution and passaged 1 : 10 into the selective media containing 700 mg/ml GENETICIN (GIBCO BRL). Surviving clones were characterized by RT ± PCR analysis for their expressions of KAI1 mRNA, and the clones with dierent levels of KAI1 expression were used for the functional experiments described. Similarly, a clone transfected with a vector (pRc/CMV) alone was used as a control.
MTT assay
Cell growth was measured using a modi®ed 3-[4, 5 -dimethylthiazol -2 -yl] -2,5-diphenyltetrazolium bromide (MTT) method (Mosmann, 1983; Tada et al., 1986) . Cells were seeded into 96-well plates at 1610 4 cells per well in culture media (100 ml). The plates were incubated for up to 4 days. In the MTT assay, 10 ml of the MTT solution (5 mg/ml) were added to each well and the cells were cultured for another 4 h and then 100 ml of isopropanol-0.04 N HCl were added to each well, mixed vigorously to solubilize colored crystals produced within the cells. The ratio of absorbance at 590 nm to absorbance at 630 nm as reference wave was measured by a multiwell scanning spectrophotometer (Titertek multiskan, Flow Laboratories). Cell viability was examined by trypan blue dye exclusion test.
Cell aggregation assay
Cell aggregation experiments were performed following the procedure by Rojas et al. (1990) with slight modi®cation. Adherent tumor cells were rendered single cell suspensions by a 5 min incubation at 378C with 5 mM EDTA in phosphate buered saline (PBS) lacking Ca ++ and Mg ++ and by 2 passes through a 27-gauge needle. Twenty fourwell plates were used for the assay of cell aggregation. Suspensions of single cells were washed three times with Puck's saline (5 mM KCl, 140 mM NaCl, 8 mM NaHCO 3 , pH 7.4), resuspended at a concentration of 1610 5 cells/ml in 1 ml of Puck's saline plus 0.8% FBS, 50 U/ml deoxyribonuclease I (Sigma Co., St. Louis, MO), and incubated in an atmosphere of 5% CO 2 -95% air at 378C, agitated at 70 ± 80 r.p.m. with a gyratory shaker. Samples were taken at the points of 1 h-and 2 h-incubation, and both the total cell numbers (A) and the number of cells remaining as single cells (B) were counted under a microscope on three predetermined ®elds. The results were shown as the percentage of cells that formed aggregates as follows: (A ± B)/A6100 [%] . To determine the Ca ++ dependence of aggregation, suspensions of single cells were resuspended according to the general procedure at 1610 5 cells/ml of Puck's saline plus 0.8% FBS, 50 U/ml DNase I with either 5 mM Ca ++ or 0 mM Ca ++ , these suspensions were stirred at 378C, and the aggregation rate was calculated as above.
Phagokinetic track motility assay
Cell motility was determined on the basis of phagokinetic tracks on a gold particle-coated plate. Brie¯y, uniform carpets of gold particles were prepared on cover slips coated with bovine serum albumin, as previously described by Albrecht-Buchler (1977) . The cover slips were rinsed extensively to remove nonadhering gold particles before cell plating. Colloidal-gold-coated coverslips were placed in 35 mm tissue culture dishes containing 2 ml culture medium, and then 5610 3 freshly trypsinized cells were added to each plate and left in the incubator for 24 h. Photographs were taken, and areas cleared by a single cultured cell were traced on semitransparent paper of uniform thickness. The particle-free areas of at least 40 individual cells were measured, and average areas were calculated.
Cell invasion assay
This assay was based on the methods described by Albini et al. (1987) , Repesh (1989) , and Parish et al. (1992) . We used 6-well BIOCOAT MATRIGEL Invasion Chambers (Becton Dickinson, Bedford, MA) that consist of Cell Culture Inserts (Falcon, Oxnard, CA) containing an 8 mm pore size polycarbonate membrane that has been coated with a solubilized tissue basement membrane`MATRI-GEL' (Collaborative Research, Bedford, MA), 100 mg/cm 2 . Brie¯y, after rehydration of the membrane, 1.5610 4 cells were added into each upper compartment. After 24 h culture, the non-invasive cells and matrigel were removed with a cotton swab, and the cells which had migrated through the membrane and stuck to the lower surface of the polycarbonate membrane were ®xed with methanol and stained with Giemsa's staining solution (GIBCO BRL). For quanti®cation, cells that had migrated to the lower surface were counted under a microscope in ®ve predetermined ®elds at a magni®cation of 6200.
Attachment assay
The cell attachment assay was based on the method described by Furukawa et al. (1993) . Fibronectin (10 mg/ well) was added to 96-well plates, which were incubated for 24 h, to allow binding to the surface of the well. The plates were then washed by PBS and, bovine serum albumin (BSA) (1.5% w/v) was added to them, which were incubated for 1 h at 378C to block remaining binding sites. Cells were detached with 5 mM EDTA/PBS and resuspended in culture media containing 0.02% BSA and counted with a hemocytometer. The number of cells was adjusted to 2610 5 /ml in culture media with 0.02% BSA; an aliquot (200 ml) of cell suspension was added to each ®bronectin-coated well. Cells were incubated at 378C in a humidi®ed atmosphere of 95% air and 5% CO 2 for 1 h. Cell attachment was veri®ed by crystal violet staining (Gillies et al., 1986) . Brie¯y, after unbound cells were removed by aspiration, 100 ml of 0.04% crystal violet solution was added and incubated for 10 min at room temperature, followed by one wash with PBS. The crystal violet that absorbed onto the cells was solubilized with 0.1% TritonX-100 (Sigma). The absorbance was measured at 590 nm with a microplate reader. Each experiment was performed in quadruplicate wells, and the cell attachment to ®bronectin was determined as follows: cells bound (%)=(mean absorbance of cells attached to wells/mean absorbance of total number of cells)6100.
Wound assay
5610
5 transfectants were seeded in 2 ml of culture medium containing 10% FBS in 35 mm plastic plates which had been preincubated with ®bronectin or non-treated dishes. After 24 h, a wound was made in the con¯uent monolayer with a disposable pipette tip as described by Burk (1973) with slight modi®cation. The medium and debris were aspirated away and replaced by 2 ml of fresh medium. For the evaluation, photographs of wounded areas were taken both just after making a wound and after 24 h-incubation. The migration was quanti®ed by calculating ®lling rate (%)=(A ± B)/A6100 [A, width of a wounded area at the starting; B, width of a wounded area after 24 hincubation]. Each sample was tested in triplicate and data represent the mean plus or minus the standard error of the mean (+s.e.m.).
Immunohistochemistry
Surgically resected 14 primary and four metastatic colonic cancer tissues were obtained from the patients treated at Sapporo Medical University Hospital. Immunohistochemical staining was done on AMeX-®xed (Sato et al., 1986) and paran-embedded tissue sections by an immunoperoxidase method as described previously (Ohe et al., 1994) . Brie¯y, each section was deparanized, rehydrated and incubated with fresh 0.3% hydrogen peroxide in methanol for 20 min at room temperature and then washed with PBS. Normal goat serum (5%) was applied for 20 min and removed by blotting. The sections were incubated with anti-KAI1 polyclonal antibody (Santa Cruz Biotechnology, Inc.) for 60 min at room temperature, washed three times in PBS, and incubated with secondary antibody (peroxidase-conjugated goat anti-rabbit Ig diluted 1/50 in PBS) for 30 min at room temperature. After washing three times, the sections were incubated with diaminobenzidine tetrahydrochloride in 0.03% hydrogen peroxide for 5 ± 10 min, washed, counterstained with hematoxylin, rinsed in tap water and mounted. Diluted rabbit serum was used as a negative control for the primary antibody. Histological classi®cation of colon cancer was according to Jass and Sobin (1989) .
Statistical evaluation
Dierences between control and experimental groups were evaluated using the Student's t-test, by the Statworks program. A P-value50.05 was considered signi®cant.
